Silverback Therapeutics shares owned by Ameriprise Financial
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Ameriprise Financial
from 13F filings
Historical chart of Ameriprise Financial investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Ameriprise Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $732k | 69k | 10.55 |
| 2024-09-30 | $471k | 32k | 14.50 |
| 2024-03-31 | $353k | 35k | 10.22 |
| 2023-09-30 | $584k | 155k | 3.78 |
| 2023-06-30 | $1.9M | 276k | 6.70 |
| 2023-03-31 | $1.8M | 280k | 6.51 |
| 2022-12-31 | $302k | 35k | 8.53 |
| 2022-09-30 | $197k | 37k | 5.28 |
| 2021-06-30 | $14M | 448k | 30.89 |
| 2021-03-31 | $19M | 426k | 43.63 |
| 2020-12-31 | $20M | 429k | 46.29 |